BDX
Price
$226.39
Change
+$0.35 (+0.15%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
71.49B
29 days until earnings call
STE
Price
$227.66
Change
+$1.94 (+0.86%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
22.22B
48 days until earnings call
Ad is loading...

BDX vs STE

Header iconBDX vs STE Comparison
Open Charts BDX vs STEBanner chart's image
Becton Dickinson and
Price$226.39
Change+$0.35 (+0.15%)
Volume$16.5K
Capitalization71.49B
STERIS
Price$227.66
Change+$1.94 (+0.86%)
Volume$901
Capitalization22.22B
BDX vs STE Comparison Chart
Loading...
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDX vs. STE commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Hold and STE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BDX: $226.04 vs. STE: $225.72)
Brand notoriety: BDX and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BDX: 85% vs. STE: 143%
Market capitalization -- BDX: $71.49B vs. STE: $22.22B
BDX [@Medical Specialties] is valued at $71.49B. STE’s [@Medical Specialties] market capitalization is $22.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whileSTE’s FA Score has 0 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • STE’s FA Score: 0 green, 5 red.
According to our system of comparison, STE is a better buy in the long-term than BDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 3 TA indicator(s) are bullish while STE’s TA Score has 3 bullish TA indicator(s).

  • BDX’s TA Score: 3 bullish, 5 bearish.
  • STE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BDX is a better buy in the short-term than STE.

Price Growth

BDX (@Medical Specialties) experienced а -0.89% price change this week, while STE (@Medical Specialties) price change was +1.78% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +3.01%.

Reported Earning Dates

BDX is expected to report earnings on May 01, 2025.

STE is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($71.5B) has a higher market cap than STE($22.2B). BDX has higher P/E ratio than STE: BDX (55.97) vs STE (38.85). STE YTD gains are higher at: 10.091 vs. BDX (0.088). BDX has higher annual earnings (EBITDA): 4.28B vs. STE (1.39B). BDX has more cash in the bank: 1.18B vs. STE (196M). STE has less debt than BDX: STE (3.51B) vs BDX (16.1B). BDX has higher revenues than STE: BDX (19.5B) vs STE (5.41B).
BDXSTEBDX / STE
Capitalization71.5B22.2B322%
EBITDA4.28B1.39B307%
Gain YTD0.08810.0911%
P/E Ratio55.9738.85144%
Revenue19.5B5.41B361%
Total Cash1.18B196M603%
Total Debt16.1B3.51B459%
FUNDAMENTALS RATINGS
BDX vs STE: Fundamental Ratings
BDX
STE
OUTLOOK RATING
1..100
5817
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
7940
SMR RATING
1..100
8078
PRICE GROWTH RATING
1..100
5348
P/E GROWTH RATING
1..100
8353
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (10) in the Medical Specialties industry is somewhat better than the same rating for STE (69). This means that BDX’s stock grew somewhat faster than STE’s over the last 12 months.

STE's Profit vs Risk Rating (40) in the Medical Specialties industry is somewhat better than the same rating for BDX (79). This means that STE’s stock grew somewhat faster than BDX’s over the last 12 months.

STE's SMR Rating (78) in the Medical Specialties industry is in the same range as BDX (80). This means that STE’s stock grew similarly to BDX’s over the last 12 months.

STE's Price Growth Rating (48) in the Medical Specialties industry is in the same range as BDX (53). This means that STE’s stock grew similarly to BDX’s over the last 12 months.

STE's P/E Growth Rating (53) in the Medical Specialties industry is in the same range as BDX (83). This means that STE’s stock grew similarly to BDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXSTE
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
51%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
46%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 16 days ago
47%
Bullish Trend 7 days ago
58%
Declines
ODDS (%)
Bearish Trend 8 days ago
40%
Bearish Trend 21 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
28%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Ad is loading...
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISSC6.420.13
+2.07%
Innovative Solutions and Support
PFGC79.450.82
+1.04%
Performance Food Group Company
NUVB1.75-0.01
-0.57%
Nuvation Bio
LGHL3.20-0.06
-1.84%
Lion Group Holding Ltd
FOLD7.95-0.21
-2.57%
Amicus Therapeutics